News • Chronic obstructive pulmonary disease
One step closer to COPD population screening
A multicenter study involving leading hospitals across Spain, has confirmed that people with COPD show altered levels of specific metabolites in their blood.
News • Staining instrument family
New pathology lab solutions debut at ECP 2025
Agilent Technologies Inc. announced the introduction of its Dako Omnis family of instruments with three new models—Agilent Dako Omnis 110, 165, and 165 Duo—designed to meet the evolving needs of pathology laboratories of all sizes.
Article • Blood-based biomarkers under scrutiny
BBB testing for universal Alzheimer’s screening? It’s complicated
Do laboratory tests using blood-based biomarkers (BBB) represent the next type of universally recommended screening tests for Alzheimer's disease (AD)? Experts curb the high expectations for this type of diagnostic tool.
News • Patient involvement enables research
Tumor vesicles as a promising biomarker for early cancer detection
Tumor vesicles may serve as early indicators of cancer and help monitor the effectiveness of treatments. Now, researchers discovered a new way to detect these vesicles.
News • Predictive phenotypes
Ovarian cancer: new insights into immune landscapes
Defining four different immunologic subtypes of recurrent ovarian cancers, researchers pave the way for more personalized treatment.
News • Viral persistence in the brainstem
Long Covid: Researchers find clues for "brain fog" origin
After an infection with the coronavirus Sars-CoV-2, the virus is able to persist at low levels in the brainstem, new research finds. This helps explain some of the enduring neurological symptoms.
News • Risk of misclassification
Prostate cancer: why “low-grade” might not be “low risk”
Classifying prostate cancer as “low-grade” could create a false sense of security and delay definitive treatments. A new study shows that the biopsy grade alone can paint an incomplete picture.
News • Respiratory viruses wake up cells in the lungs
How Covid-19 and flu infections revive dormant breast cancer
Common respiratory infections such as influenza and Covid-19 can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors, new research finds.
Article • Sustainable workflows
Designing the laboratory of the future
Laboratories across Europe are embracing sustainability through paperless workflows and automation. In this guest article, Gavin Hirst, Clinical Flow Cytometry Account Manager at Beckman Coulter Life Sciences, shares his thoughts on how digital transformation and eco-friendly practices not only advance climate goals but enhance efficiency, allowing scientists to focus on critical research rather…
News • Weakened defenses
Antibiotics are not the only meds disrupting the gut microbiome
Antibiotics are known for disrupting the microbiome in the gut and thus paving the way for diseases. However, many common non-antibiotics also have this effect, a new study shows.
News • Raman spectroscopy and interpretable machine learning
AI-assisted tissue differentiation for smart surgical tools
By identifying the unique biological signatures that guide AI tissue classification, new research lays the foundation for smart surgical tools with the added feature of biomolecular-level precision.
News • Neurodegenerative disease
Alzheimer's: middle-age brain biomarkers give an earlier shot at prevention
The earlier Alzheimer's disease is detected, the more effective treatments become. Now, a Finnish study shows that signs related to Alzheimer’s may already be found in the brain in middle age.
News • Tracking current and emerging threats
Combined wastewater and individual testing for better virus detection
When someone is infected with a virus, traces of it are shed in their bodily waste and end up in the sewage system. Thus, combined wastewater and individual testing can benefit public health response.
News • Study shows benefits of earlier FIT
Colorectal cancer screening: 40 is the new 50
Starting fecal immunochemical testing (FIT) early significantly reduces both the incidence and mortality of colorectal cancer. These results of a new study support earlier screening.
News • Assessment of tumour-infiltrating lymphocytes
Skin cancer: AI assistance helps pathologists identify melanoma
More consistent TIL assessments, more accurate patients' prognoses: New research shows how AI sharpens pathologists' interpretation of tissue samples for malignant melanoma.
News • Potential diagnostic medium
Saliva analysis could reveal risk of cancer, heart disease or Parkinson’s
Molecular markers in saliva could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases, new research finds.
News • Integration of digital pathology and AI tools
Digital pathology partnership to streamline workflows and enhance diagnostics
Digital pathology software company Fujifilm Healthcare Europe and Ibex Medical Analytics, specializing in AI-powered cancer diagnostics, announce a formal partnership to support efficient and accurate cancer diagnosis.
News • MRD assessment
Liquid biopsy to detect breast cancer relapse up to 5 years in advance
Newly developed technology can detect breast cancer relapses up to five years in advance. This advance could represent a turning point in post-treatment follow-up, the researchers hope.
News • NHS rollout
Liquid biopsy: new ‘blood test-first’ approach for lung cancer
A new ‘liquid biopsy’ test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping avoid further tests and treatments including chemotherapy.
News • Precision medicine
Melanoma: with 43,000 data points to tailored treatments
Using nine different molecular biological technologies, researchers were able to precisely measure the properties of a melanoma tumor in four weeks and enable a precise treatment decision.
News • Stratification of TSCC immunotypes
Tongue cancer: Immune profiling for improved outcomes
Tongue squamous cell carcinoma, the most common type of oral cancer, is a challenging target for immunotherapies. Researchers now identified five immunotypes to better predict treatment response.
News • Barrier effect research
Using bacteria to improve microbiota resistance to pathogens
Microbiota composition can help prevent pathogenic bacteria from proliferating, known as the barrier effect. Now, scientists have identified seven bacteria involved, paving the way for new therapies.
News • Early detection of life-threatening conditions
Newborn immune profiling to improve neonatal care
Newborns, especially those born prematurely, are vulnerable to conditions such as sepsis. A new device profiles an infant’s immune function from a single drop of blood to improve neonatal care.
News • Promising protein analysis tool
New blood test to enable rapid diagnosis of rare genetic diseases
An Australian research team has developed a blood-based method of analysing thousands of proteins in a single, untargeted test. This potentially enables rapid diagnosis of many rare genetic diseases.
News • Intestinal disease diagnosis
Next-generation tools find infections missed by standard tests
A University of Liverpool study has used advanced genetic and genomic techniques to offer a major step forward in understanding and diagnosing infectious intestinal diseases.
